GeneTex
  • Country / Location Selection

United States (US)

LSD2 / AOF1 blocking peptide

Cat No. GTX32122-PEP

Application

Neutralizing/Blocking
Package
50 μg ($169)
PRODUCT

Summary

LSD2 / AOF1 peptide is used for blocking the activity of LSD2 / AOF1 antibody (catalog number GTX32122). It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37ºC.

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
Neutralizing/Blocking Assay dependent
Not tested in other applications.

PROPERTIES

Form

Liquid

Buffer

PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl), 0.1% BSA, 0.02% sodium azide

Storage

Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.

Concentration

200 μg/ml (Please refer to the vial label for the specific concentration.)

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Lysine Demethylase 1B , Aof1 , C6Orf193 , Lsd2 , Ba204B7.3 , Dj298J15.2 , Kdm1B

Background

Flavin-dependent histone demethylases, such as KDM1B, regulate histone lysine methylation, an epigenetic mark that regulates gene expression and chromatin function (Karytinos et al., 2009 [PubMed 19407342]).[supplied by OMIM, Oct 2009]

Research Area

REFERENCE

There are currently no references for LSD2 / AOF1 blocking peptide (GTX32122-PEP). Be the first to share your publications with this product.

REVIEW

There are currently no reviews for LSD2 / AOF1 blocking peptide (GTX32122-PEP). Be the first to share your experience with this product.
Package List Price ($)
$ 169